Episode 458: Novartis CEO Vas Narasimhan on Drug Development & AI's Role in Disease Treatment

from Inside the ICE House · host Intercontinental Exchange

The pharmaceutical industry is experiencing extraordinary innovation, fueled by breakthroughs in science, technology, and data analytics. Novartis (NYSE: NVS) stands as a driving force in this wave of transformation. From gene and cell therapies to targeted cancer treatments and immunology, Novartis consistently delivers solutions for some of the most complex health problems. CEO Vas Narasimhan goes Inside the ICE House to discuss the significant success achieved and how the company, under his leadership, sharpened its focus on innovative medicines to combat some of the world's most pressing medical challenges. https://www.ice.com/insights/conversations/inside-the-ice-house

Episode metadata supplied by the publisher feed · Published Feb 17, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 458: Novartis CEO Vas Narasimhan on Drug Development & AI's Role in Disease Treatment

0:00 33:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Inside the ICE House?

This episode is 33 minutes long.

When was this Inside the ICE House episode published?

This episode was published on February 17, 2025.

Can I download this Inside the ICE House episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!